Skin Cancer
Researchers building melanoma vaccine to combat skin cancer
Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, ...
Cancer
Mar 19, 2012 |
5 / 5 (11) |
0
|
Preventing the skin cancer, not just the sunburn
(Medical Xpress) -- With the first day of spring just one week away, anyone who spends time in the sun should be aware of new sunscreen regulations designed to help prevent skin cancer.
Cancer
Mar 14, 2012 |
5 / 5 (2) |
0
Dose-Response link between tanning bed use, skin cancer
(HealthDay) -- Use of tanning beds, especially in high school and college, is associated with an increased risk of skin cancer, according to a study published online Feb. 27 in the Journal of Clinical Oncology.
Cancer
Feb 28, 2012 |
5 / 5 (1) |
0
Skin cancer frequency in chronic leg ulcers >10 percent
(HealthDay) -- Chronic leg ulcers (CLUs) that don't heal after three months of appropriate treatment have an overall skin cancer frequency of 10.4 percent, according to a study published online Feb. 20 in ...
Diseases, Conditions, Syndromes
Feb 22, 2012 |
5 / 5 (1) |
0
EU approves skin cancer fighting drug: Roche
Swiss drug giant Roche said on Monday it had been given European Union approval for its treatment to fight a highly aggressive form of skin cancer.
Cancer
Feb 20, 2012 |
5 / 5 (1) |
0
FDA approves new skin cancer drug
A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable ...
Cancer
Feb 01, 2012 |
not rated yet |
0
FDA approves Roche skin cancer drug Erivedge
(AP) -- Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
Medications
Jan 30, 2012 |
5 / 5 (1) |
0
Study uncovers mechanism by which melanoma drug accelerates secondary skin cancers
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer. Now, researchers at UCLA's ...
Cancer
Jan 18, 2012 |
5 / 5 (1) |
0
|
Immune cell can trigger skin cancer caused by toxins
(Medical Xpress) -- Researchers based jointly at Kings College London and the Cancer Research UK London Research Institute, together with collaborators at Yale University have found that a type of immune ...
Immunology
Jan 09, 2012 |
5 / 5 (1) |
0
Lower antioxidant level might explain higher skin-cancer rate in males
Men are three times more likely than women to develop a common form of skin cancer but medical science doesn't know why. A new study may provide part of the answer.
Cancer
Dec 02, 2011 |
not rated yet |
0
|
Internal skin cancer prevention: Repairing UV damage in the skin
(Medical Xpress) -- Scientists at the Friedrich Miescher Institute for Biomedical Research (FMI) of the Novartis Research Foundation have elucidated the mechanisms underlying the repair of UV-induced damage ...
Cancer
Nov 24, 2011 |
not rated yet |
0
IBD patients face increased skin cancer risk
Certain patients with inflammatory bowel disease (IBD) may have an increased risk of skin cancer, which is intensified by the use of immunosuppressant medications , according to two new studies in Gastroenterology, the of ...
Diseases, Conditions, Syndromes
Nov 21, 2011 |
not rated yet |
0
Stop signal discovered for skin cancer
(Medical Xpress) -- An extraordinary breakthrough in understanding what stops a common form of skin cancer from developing could make new cancer treatments and prevention available to the public in five years.
Cancer
Nov 15, 2011 |
5 / 5 (7) |
1
Suggested link between radon and skin cancer
A new study published this week suggests that a link may exist between radon exposure and non-melanoma skin cancer.
Cancer
Nov 14, 2011 |
not rated yet |
0
Researchers identify skin cancer genes
(Medical Xpress) -- The genes which contribute to the most frequently occurring life threatening form of skin cancer have been identified for the first time by a research collaboration between the University ...
Cancer
Nov 10, 2011 |
5 / 5 (1) |
0
Skin neoplasms (also known as "skin cancer") are skin growths with differing causes and varying degrees of malignancy. The three most common malignant skin cancers are basal cell cancer, squamous cell cancer, and melanoma, each of which is named after the type of skin cell from which it arises. Skin cancer generally develops in the epidermis (the outermost layer of skin), so a tumor can usually be seen. This means that it is often possible to detect skin cancers at an early stage. Unlike many other cancers, including those originating in the lung, pancreas, and stomach, only a small minority of those affected will actually die of the disease, though it can be disfiguring. Melanoma survival rates are poorer than for non-melanoma skin cancer, although when melanoma is diagnosed at an early stage, treatment is easier and more people survive.
Skin cancer is the most commonly diagnosed type of cancer. Melanoma and non-melanoma skin cancers combined are more common than lung, breast, colorectal, and prostate cancer. Melanoma is less common than both basal cell carcinoma and squamous cell carcinoma, but it is the most serious — for example, in the UK there were over 11,700 new cases of melanoma in 2008, and over 2,000 deaths. It is the second most common cancer in young adults aged 15–34 in the UK. Most cases are caused by over-exposure to UV rays from the sun or sunbeds. Non-melanoma skin cancers are the most common skin cancers. The majority of these are basal cell carcinomas. These are usually localized growths caused by excessive cumulative exposure to the sun and do not tend to spread.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Researchers complete largest genetic sequencing study of human disease
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Having both migraines, depression may mean smaller brain
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...
Research offers promising new approach to treatment of lung cancer
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...
Study details genes that control whether tumors adapt or die when faced with p53 activating drugs
When turned on, the gene p53 turns off cancer. However, when existing drugs boost p53, only a few tumors die – the rest resist the challenge. A study published in the journal Cell Reports shows how: tumors that live even i ...
Overeating learned in infancy, study suggests
In the long run, encouraging a baby to finish the last ounce in their bottle might be doing more harm than good.
Research shows how immune system peacefully co-exists with 'good' bacteria
The human gut is loaded with commensal bacteria – "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the ...